Giacomo Dal Bello
Mantova, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Predictors of outcomes and satisfaction with tirbanibulin in actinic keratosis: a multicenter real-world study.
Journal: Italian journal of dermatology and venereology
Published: August 24, 2026
Longitudinal Response Trajectories with Dupilumab or Upadacitinib in Moderate-to-Severe Atopic Dermatitis: A Multicentre Real-World Study: IL-AD (Italian Landscape Atopic Dermatitis).
Journal: Dermatology and therapy
Published: March 17, 2026
Tirbanibulin 1% real-world use in 679 actinic keratoses patients during warm season (SUMM-AK study).
Tirbanibulin 1% real-world use in 679 actinic keratoses patients during warm season (SUMM-AK study).
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: July 28, 2025
Safety and Effectiveness of Dupilumab in Atopic Dermatitis Patients with Hematologic Comorbidities: A Multicenter, Retrospective Study.
Journal: Antibodies (Basel, Switzerland)
Published: July 24, 2025
Effectiveness, speed of action and safety of brodalumab in elderly psoriasis patients: a multicenter real-world study - IL PSO (Italian Landscape Psoriasis).
Journal: The Journal of dermatological treatment
Published: February 06, 2025
BRodalumab effectiveness in psoriatic patients that experienced anti-IL17 Intra-Class failure: a multicentre, retrospective study (BRIC - Study) IL-PSO (Italian Landscape Psoriasis).
Journal: Clinical and experimental dermatology
Published: January 17, 2025
Effectiveness of Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: A Retrospective, Real-World Multicenter Study with a Focus on Obese and Multi-Failure Patients-IL PSO (Italian Landscape Psoriasis).
Journal: Journal of clinical medicine
Published: December 31, 2024
The risk of candidiasis during treatment with bimekizumab for the management of plaque psoriasis: a 16-week multicentre real-world experience - IL PSO (Italian Landscape Psoriasis).
Journal: Clinical and experimental dermatology
Published: September 15, 2024
Efficacy and Safety of bimekizumab in elderly patients: real-world multicenter retrospective study - IL PSO (Italian Landscape Psoriasis).
Journal: The Journal of dermatological treatment
Published: August 20, 2024
Identification of clinical predictors for dupilumab dose spacing in adults with atopic dermatitis: a real-world study.
Journal: The Journal of dermatological treatment
Published: July 14, 2023
Upadacitinib in patients with resistant atopic dermatitis: a retrospective case-series.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: November 11, 2021
Dupilumab in adolescents with moderate to severe atopic dermatitis: a 32-week real-world experience during the COVID-19 pandemic.
Journal: Clinical and experimental dermatology
Published: July 22, 2021
Last Updated: 09/26/2026